Stockreport

Sagimet Biosciences to Participate in Two Upcoming Investor Conferences

Sagimet Biosciences Inc.  (SGMT) 
PDF SAN MATEO, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) --  Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fa [Read more]